Literature DB >> 30408627

A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma.

Yiting Geng1, Danxia Zhu1, Chen Wu1, Jun Wu1, Qi Wang1, Ruiqi Li1, Jingting Jiang2, Changping Wu3.   

Abstract

BACKGROUND: Inflammation is closely associated with the initiation and development of tumors. Based on the counts of peripheral neutrophils, monocytes and lymphocytes, we established a new systemic inflammation response index (SIRI) to predict postoperative survival of patients with esophageal squamous cell carcinoma (ESCC).
METHODS: A total of 916 ESCC patients treated with radical esophagectomy were enrolled in the present study.
RESULTS: Survival analysis indicated that the median overall survival (OS) in patients with SIRI≤1.2 was significantly higher than that in patients with SIRI>1.2. The nomogram including SIRI could more accurately predict OS compared with the TNM staging system. In addition, the changes of SIRI from baseline to 8 weeks after the operation were correlated with patient survival. The patients with an increase in SIRI >75% had worse OS compared with those with no change, while the patients with a decrease in SIRI >75% or in the scope of 25% ~75% exhibited better OS.
CONCLUSIONS: SIRI was an independent prognostic index of ESCC patients after the radical resection. The nomogram integrating the SIRI could help clinicians to screen the high-risk patients and formulate the individualized treatment schemes.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; Prognosis; Systemic inflammation response index

Mesh:

Year:  2018        PMID: 30408627     DOI: 10.1016/j.intimp.2018.10.002

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  34 in total

1.  Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.

Authors:  Cristina Valero; Daniella K Zanoni; Marlena R McGill; Ian Ganly; Luc G T Morris; Miquel Quer; Jatin P Shah; Richard J Wong; Xavier León; Snehal G Patel
Journal:  Cancer       Date:  2019-12-06       Impact factor: 6.860

2.  Prognostic Value of the Systemic Inflammatory Response Index in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Population-Based Study.

Authors:  Jinliang Ni; Keyi Wang; Houliang Zhang; Jinbo Xie; Jun Xie; Changxiu Tian; Yifan Zhang; Weiyi Li; Bin Su; Chaozhao Liang; Xinran Song; Bo Peng
Journal:  Front Oncol       Date:  2021-08-16       Impact factor: 6.244

3.  Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke.

Authors:  Kai-Bin Lin; Feng-Hua Fan; Ming-Qi Cai; Yin Yu; Chuan-Liang Fu; Lu-Yue Ding; Yu-Dong Sun; Jia-Wen Sun; Yong-Wang Shi; Zhi-Feng Dong; Min-Jie Yuan; Shuai Li; Yan-Peng Wang; Kan-Kai Chen; Ji-Ni Zhu; Xin-Wei Guo; Xue Zhang; Yu-Wu Zhao; Jing-Bo Li; Dong Huang
Journal:  Eur J Med Res       Date:  2022-07-02       Impact factor: 4.981

4.  Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Kangning Han; Dongmei Shi; Lixia Yang; Zhijian Wang; Yueping Li; Fei Gao; Yuyang Liu; Xiaoteng Ma; Yujie Zhou
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

5.  High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients.

Authors:  Weiwei Gao; Fei Zhang; Tai Ma; Jiqing Hao
Journal:  J Gastric Cancer       Date:  2020-05-06       Impact factor: 3.720

6.  A Novel Prognostic Marker Systemic Inflammation Response Index (SIRI) for Operable Cervical Cancer Patients.

Authors:  Bei Chao; Xiaoli Ju; Lirong Zhang; Xin Xu; Yan Zhao
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

7.  The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram.

Authors:  Qian He; Longhao Li; Qinglan Ren
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

8.  Evidence of the Prognostic Value of Pretreatment Systemic Inflammation Response Index in Cancer Patients: A Pooled Analysis of 19 Cohort Studies.

Authors:  Yi Zhang; Fangteng Liu; Yang Wang
Journal:  Dis Markers       Date:  2020-08-31       Impact factor: 3.434

9.  Combination of Systemic Inflammation Response Index and Platelet-to-Lymphocyte Ratio as a Novel Prognostic Marker of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.

Authors:  Yangqin Zheng; Yuming Chen; Jingfeng Chen; Wu Chen; Yue Pan; Lianmin Bao; Xiaomin Gao
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

10.  Systemic Inflammation Response Index is a Prognostic Risk Factor in Patients with Hepatocellular Carcinoma Undergoing TACE.

Authors:  Jun-Xiang Li; Peng-Fei Pang; Tian-Cheng Wang; Tian-Zhi An
Journal:  Risk Manag Healthc Policy       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.